BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1076 related articles for article (PubMed ID: 22758907)

  • 1. Oral 5-aminolevulinic acid in simultaneous photodynamic diagnosis of upper and lower urinary tract transitional cell carcinoma - a prospective audit.
    Ahmad S; Aboumarzouk O; Somani B; Nabi G; Kata SG
    BJU Int; 2012 Dec; 110(11 Pt B):E596-600. PubMed ID: 22758907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hexylaminolaevulinate 'blue light' fluorescence cystoscopy in the investigation of clinically unconfirmed positive urine cytology.
    Ray ER; Chatterton K; Khan MS; Thomas K; Chandra A; O'Brien TS
    BJU Int; 2009 May; 103(10):1363-7. PubMed ID: 19076151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photodynamic diagnosis (PDD) for upper urinary tract transitional cell carcinoma (UT-TCC): evolution of a new technique.
    Somani BK; Moseley H; Eljamel MS; Nabi G; Kata SG
    Photodiagnosis Photodyn Ther; 2010 Mar; 7(1):39-43. PubMed ID: 20230992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-aminolevulinic acid-mediated photodynamic diagnosis using fluorescence ureterorenoscopy for urinary upper tract urothelial carcinoma ∼Preliminary prospective single centre trial∼.
    Fukuhara H; Kurabayashi A; Furihata M; Setuda S; Takahashi K; Murakami K; Tanaka T; Inoue K
    Photodiagnosis Photodyn Ther; 2020 Mar; 29():101617. PubMed ID: 31857216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder.
    Hungerhuber E; Stepp H; Kriegmair M; Stief C; Hofstetter A; Hartmann A; Knuechel R; Karl A; Tritschler S; Zaak D
    Urology; 2007 Feb; 69(2):260-4. PubMed ID: 17320660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between intravesical and oral administration of 5-aminolevulinic acid in the clinical benefit of photodynamic diagnosis for nonmuscle invasive bladder cancer.
    Inoue K; Fukuhara H; Shimamoto T; Kamada M; Iiyama T; Miyamura M; Kurabayashi A; Furihata M; Tanimura M; Watanabe H; Shuin T
    Cancer; 2012 Feb; 118(4):1062-74. PubMed ID: 21773973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic diagnostic ureterorenoscopy: A valuable tool in the detection of upper urinary tract tumour.
    Kata SG; Aboumarzouk OM; Zreik A; Somani B; Ahmad S; Nabi G; Buist R; Goodman C; Chlosta P; Golabek T; Moseley H
    Photodiagnosis Photodyn Ther; 2016 Mar; 13():255-260. PubMed ID: 26256824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Confocal laser endomicroscopy of bladder tumors associated with photodynamic diagnosis: an ex vivo pilot study.
    Bonnal JL; Rock A; Gagnat A; Papadopoulos S; Filoche B; Mauroy B
    Urology; 2012 Nov; 80(5):1162.e1-5. PubMed ID: 22950991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of upper urinary tract tumours: is photodynamic diagnosis assisted ureterorenoscopy required as an addition to modern imaging and ureterorenoscopy?
    Aboumarzouk OM; Mains E; Moseley H; Kata SG
    Photodiagnosis Photodyn Ther; 2013 May; 10(2):127-33. PubMed ID: 23769278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced specificity of 5-ALA induced fluorescence in photodynamic diagnosis of transitional cell carcinoma after previous intravesical therapy.
    Grimbergen MC; van Swol CF; Jonges TG; Boon TA; van Moorselaar RJ
    Eur Urol; 2003 Jul; 44(1):51-6. PubMed ID: 12814675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical experience with intravesical instillations of 5-aminolevulinic acid (5-ALA) for the photodynamic diagnosis using fluorescence cystoscopy for bladder cancer].
    Inoue K; Karashima T; Kamada M; Kurabayashi A; Ohtsuki Y; Shuin T
    Nihon Hinyokika Gakkai Zasshi; 2006 Jul; 97(5):719-29. PubMed ID: 16898595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of the photodynamic method in the diagnosis of superficial bladder tumors].
    Lipiński MI; Jeromin LM
    Wiad Lek; 2004; 57 Suppl 1():192-5. PubMed ID: 15884237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical trial on the safety and effectiveness of the photodynamic diagnosis of non-muscle-invasive bladder cancer using fluorescent light-guided cystoscopy after oral administration of 5-aminolevulinic acid (5-ALA).
    Inoue K; Matsuyama H; Fujimoto K; Hirao Y; Watanabe H; Ozono S; Oyama M; Ueno M; Sugimura Y; Shiina H; Mimata H; Azuma H; Nagase Y; Matsubara A; Ito YM; Shuin T
    Photodiagnosis Photodyn Ther; 2016 Mar; 13():91-96. PubMed ID: 26751700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral 5-aminolevulinic acid mediated photodynamic diagnosis using fluorescence cystoscopy for non-muscle-invasive bladder cancer: A randomized, double-blind, multicentre phase II/III study.
    Inoue K; Anai S; Fujimoto K; Hirao Y; Furuse H; Kai F; Ozono S; Hara T; Matsuyama H; Oyama M; Ueno M; Fukuhara H; Narukawa M; Shuin T
    Photodiagnosis Photodyn Ther; 2015 Jun; 12(2):193-200. PubMed ID: 25843912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outpatient diagnostic of bladder tumours in flexible cystoscopes: evaluation of fluorescence-guided flexible cystoscopy and bladder biopsies.
    Hermann GG; Mogensen K; Toft BG; Glenthøj A; Pedersen HM
    Scand J Urol Nephrol; 2012 Feb; 46(1):31-6. PubMed ID: 22150596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective randomized trial of hexylaminolevulinate photodynamic-assisted transurethral resection of bladder tumour (TURBT) plus single-shot intravesical mitomycin C vs conventional white-light TURBT plus mitomycin C in newly presenting non-muscle-invasive bladder cancer.
    O'Brien T; Ray E; Chatterton K; Khan MS; Chandra A; Thomas K
    BJU Int; 2013 Dec; 112(8):1096-104. PubMed ID: 24053153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hexaminolevulinate photodynamic diagnosis in non-muscle invasive bladder cancer: experience of the BLUE group].
    Burgués JP; Conde G; Oliva J; Abascal JM; Iborra I; Puertas M; Ordoño F;
    Actas Urol Esp; 2011 Sep; 35(8):439-45. PubMed ID: 21621301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study.
    Fradet Y; Grossman HB; Gomella L; Lerner S; Cookson M; Albala D; Droller MJ;
    J Urol; 2007 Jul; 178(1):68-73; discussion 73. PubMed ID: 17499291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic diagnostics and noninvasive bladder cancer: is it cost-effective in long-term application? A Germany-based cost analysis.
    Burger M; Zaak D; Stief CG; Filbeck T; Wieland WF; Roessler W; Denzinger S
    Eur Urol; 2007 Jul; 52(1):142-7. PubMed ID: 17267099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy.
    Schmidbauer J; Witjes F; Schmeller N; Donat R; Susani M; Marberger M;
    J Urol; 2004 Jan; 171(1):135-8. PubMed ID: 14665861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.